Children vaccination of COVID-19
The Delta variant is currently the highly contagious predominant variant of the SARS-CoV-2 virus worldwide that causes severe illness more than the previous variants in unvaccinated people (CDC, 2021). At a White House briefing, the National Institute of Allergy and Infectious Diseases director, Ant...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | en en |
| Published: |
Penerbit UMS
2021
|
| Subjects: | |
| Online Access: | https://eprints.ums.edu.my/id/eprint/31993/1/Children%20vaccination%20of%20COVID-19_ABSTRACT.pdf https://eprints.ums.edu.my/id/eprint/31993/2/Children%20vaccination%20of%20COVID-19.pdf https://eprints.ums.edu.my/id/eprint/31993/ https://jurcon.ums.edu.my/ojums/index.php/bjms/article/view/3357/2210 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The Delta variant is currently the highly contagious predominant variant of the SARS-CoV-2 virus worldwide that causes severe illness more than the previous variants in unvaccinated people (CDC, 2021). At a White House briefing, the National Institute of Allergy and Infectious Diseases director, Anthony Fauci, predicted that there would be an increase in the number of child hospitalisation proportionate to the increased number of children getting infected with the Delta variant (Press briefing White House, 2021). In response to this situation, the FDA (U.S. Food and Drug Administration) approved Pfizer-BioNTech and Moderna vaccines for children aged 12 – 17 years. Vaccines in children aged 5 – 11 years are currently under clinical trial (Sick-Samuels & Messina, 2021). |
|---|